Belviq (lorcaserin): The U.S. Food and drug administration, june 27, 2012, approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercis, for chronic weight management. It works best in patients who suffer from weight-related conditions, such as high blood pressure, type-2 diabetes, or high cholesterol. At least 47.5% of patients lost at least 5% of their body weight from the med.
Answered 6/24/2014
5.6k views
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question